Enanta Pharmaceuticals, Inc.ENTANASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank36
3Y CAGR-9.6%
5Y CAGR-10.6%
Year-over-Year Change
Total value of everything the company owns
3Y CAGR
-9.6%/yr
vs -2.1%/yr prior
5Y CAGR
-10.6%/yr
Consistent
Acceleration
-7.6pp
Decelerating
Percentile
P36
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $280.73M | -25.5% |
| 2024 | $376.65M | -18.5% |
| 2023 | $462.27M | +21.5% |
| 2022 | $380.59M | -13.7% |
| 2021 | $440.86M | -10.2% |
| 2020 | $490.79M | +0.2% |
| 2019 | $489.83M | +18.3% |
| 2018 | $414.23M | +26.8% |
| 2017 | $326.64M | +16.1% |
| 2016 | $281.28M | - |